News

Rx-360 Agrees to Participate in DSCSA & Blockchain VirtualPilot Study

PRESS RELEASE
Tue 31 Jan 2017

Washington, D.C. – Rx-360 is proud to be a participant in the DSCSA & Blockchain VirtualPilot Study by the Center for Supply Chain Studies, a nonprofit organization.

The goal of this Study will explore the potential use of blockchain technology as a way to establish trust between trading partners in the U.S. pharma supply chain.

Start Date: Friday, February 3rd at 11:00am (Call-in meeting information will be provided to those interested in participating)

Duration of Study: The Study is expected to last six months.

Study Participation Fee: No charge and participation is voluntary and you may select your level of activity with full access to the Study progress, final deliverables and support recognition.

Important Note: Study will be conducted without bias. Final observations will not represent the operations of any specific company or participating organization.

Role of the Center for Supply Chain Studies:

  • Simulation platform & Simulation Support Team
  • Expert analysis and Marketing/Communications support
  • Publication and archival of deliverables
  • Facilitation and logistical support

Study Deliverables:

Deliverables will be published on the Center’s website including:

  1. ReferenceModel

Models are powered by software that will run per this Study Team’s agreed-upon input parameters, rules and included data.

  • Participants will have special access to all ReferenceModel scenarios developed during this Study.
  • Only limited access will be available to the general public based upon agreed-upon scenarios of the Team.
  • Support from the Center can be arranged for each Participant who wished to adjust or augment the ReferenceModels for their individual business needs or practices.
  1. White Paper
  2. Education Modules (in the form of the Center’s VirtualPoster)

If you are interested in participating in the Blockchain VirtualPilot Study please send an email stating your interest to [email protected].

Read More